EUVIMED · CrossrefJournal
Cephalalgia
ISSN 0333-1024 · SAGE Publications
Latest articles
Small molecules, big hopes: Gepants in cluster headache
Atogepant for preventive treatment of episodic cluster headache: A single-center case series of 18 patients
Short-term gepant use during active cluster headache bouts: A consecutive case series
Sustained response to atogepant in episodic and chronic migraine: Post-hoc analyses of ELEVATE and PROGRESS, and their open-label extension
Three-year safety, tolerability, clinical efficacy, and functional outcomes of atogepant for the preventive treatment of migraine: Final results from a phase 3, open-label extension study
Uludüz D et al. Migraine and headache in children and adolescents: A 2026 evidence-based factsheet
Authors’ reply to Steiner et al.: “Migraine and headache in children and adolescents: a 2026 evidence-based factsheet”
Migraine beyond attacks: Insights on the interictal phase
Vascular risk prediction in migraine: A multimodality risk score based on artificial intelligence-electrocardiogram output, echocardiogram, and detailed migraine characteristics
Restlessness in cluster headache: Rethinking a classic feature through behaviorally-anchored assessment
Beyond pacing: What does restlessness really mean in cluster headache?
Migraine is chronic – its frequency varies: Time to reconsider ‘episodic’ and ‘chronic’ migraine terminology
Potentiation of ASIC currents by pituitary adenylate cyclase-activating polypeptide in mouse trigeminal ganglion neurons
Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study
Association between migraine and angiogenic biomarkers in women with suspected or confirmed hypertensive disorders of pregnancy
Fremanezumab for the preventive treatment of migraine in Chinese adults: A Phase 3, randomized controlled trial with an open-label extension
Migraine and headache in children and adolescents: A 2026 evidence-based factsheet
Blood levels of PACAP in migraine: A systematic review
Value of lumbar puncture in identifying secondary causes of visual snow syndrome: A case-control study
Methodological considerations regarding smoking, psychological distress, and medication-overuse headache
Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
Substance P and PACAP activate dural mast cells through MRGPRX2, not NK1R or PAC 1 /VPAC receptors
Iatrogenic harm in paediatric and adolescent populations of patients with migraine: A systematic review with meta-analysis
Endocannabinoid cerebrospinal fluid levels in migraine and its relation to symptoms of depression
Treatment patterns and Reasons for Discontinuing Preventive Treatment in Cluster Headache: A prospective cohort study
Corrigendum to: “Neuroimaging-based subtyping of migraine identifies clinically distinct phenotypes”
Abstracts from the 2026 China Headache Congress, 15-17 May 2026, Xi’an, China
Early and clinically meaningful functional improvement following CGRP monoclonal antibodies in adolescents with migraine: A real-world retrospective study
Headache in the emergency department: Sex differences in triage, diagnostic evaluation, and treatment
Volumes
2026 · 1722025 · 1942024 · 1352023 · 1582022 · 1712021 · 1502020 · 1862019 · 1952018 · 2252017 · 1852016 · 1722015 · 1802014 · 1652013 · 1622012 · 1872011 · 2332010 · 2382009 · 2162008 · 2412007 · 2472006 · 2492005 · 1862004 · 2042003 · 1752002 · 1492001 · 2392000 · 2241999 · 2271998 · 2401997 · 1781996 · 1421995 · 2961994 · 1351993 · 1641992 · 1091991 · 2501990 · 531989 · 3021988 · 741987 · 283
EUVIMED